Inci, MehmetSarli, BahadirDavarci, MurselYalcinkaya, Fatih RustuRifaioglu, Murat MehmetDavran, RamazanArica, Secil2024-09-182024-09-1820132168-18052168-1813https://doi.org/10.3109/21681805.2012.762038https://hdl.handle.net/20.500.12483/8133Objective. There are limited data on whether there is an association between nocturia, benign prostatic hyperplasia (BPH) and endothelial dysfunction. The aim of the present study was to evaluate whether there is an association between nocturia and endothelial dysfunction in patients with BPH. Material and methods. Forty-two men with a diagnosis of BPH and 42 age-matched controls were enrolled. All patients were assessed for frequency and duration of nocturia, and prostate volume, completed the International Prostate Symptom Score (IPSS) questionnaire, and underwent brachial flow-mediated dilatation (FMD) evaluation. Results. There was a negative correlation between FMD and frequency of nocturia (r = -0.879, p < 0.0001). Moreover, there was a negative correlation between duration of nocturia and FMD (r = -0.890, p < 0.0001). In addition, FMD was significantly decreased in the BPH group compared with the control group (6.0 +/- 0.09 to 7.8 +/- 0.10%) (p = 0.0001). Conclusion. In patients with BPH, nocturia is associated with endothelial dysfunction and may be an insidious risk factor for cardiovascular disease.eninfo:eu-repo/semantics/closedAccessbenign prostatic hyperplasiablood pressure variabilityendothelial dysfunctionnocturiaArticle47538438910.3109/21681805.2012.762038233237592-s2.0-84885413093Q2WOS:000325524600008Q4